193014-31-2

Basic information

• Product Name: Benzoic acid, 3-[[1-(2,4-dichlorophenyl)ethyl]amino]-4-nitro-, ethyl ester
• CAS NO: 193014-31-2
• Molecular Formula: C17H16Cl2N2O4
• Molecular Weight: 383.231
• Mol File: 193014-31-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 3-[[1-(2,4-dichlorophenyl)ethyl]amino]-4-nitro-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 3-[[1-(2,4-dichlorophenyl)ethyl]amino]-4-nitro-, ethyl ester(193014-31-2)
• EPA Substance Registry System: Benzoic acid, 3-[[1-(2,4-dichlorophenyl)ethyl]amino]-4-nitro-, ethyl ester(193014-31-2)

Safety Data

• Hazardous Substances Data: 193014-31-2(Hazardous Substances Data)

Upstream product

• 64-17-5 ethanol 
• 89981-75-9 1-(2',4'-dichlorophenyl)ethylamine 
• 403-21-4 3-fluoro-4-nitrobenzoic acid 

Relevant articles and documents

Benzimidazole compounds

A benzimidazole compound represented by the formula (I): wherein R3is a carboxyl group, a esterified carboxyl group, an amidated carboxyl group, an amino group, an amido group, or a sulfonyl group, or their pharmaceutically acceptable salts. Because of their blood sugar-depressing effect or PDE5 inhibitory effect, these compounds or salts thereof are useful as medicines for treating impaired glucose tolerance, diabetes, diabetic complications, syndrome of insulin resistance, hyperlipidemia, atherosclerosis, cardiovascular disorders, hyperglycemia, or hypertension; or stenocardia, hypertension, pulmonary hypertension, congestive heart failure, glomerulopathy, tubulointerstitial disorders, renal failure, atherosclerosis, angiostenosis, distal angiopathy, cerebral apoplexy, chronic reversible obstructions, allergic rhinitis, urticaria, glaucoma, diseases characterized by enteromotility disorders, impotence, diabetic complications, nephritis, cancerous cachexia, or restenosis after PTCA.